Question 1

How many shares of CHRS does BALYASNY ASSET MANAGEMENT L.P. own?

Accepted Answer

BALYASNY ASSET MANAGEMENT L.P. previously held 0 shares of CHRS (COHERUS ONCOLOGY INC) before exiting the position in 2024-Q1.

Question 2

What is BALYASNY ASSET MANAGEMENT L.P.'s CHRS position worth?

Accepted Answer

BALYASNY ASSET MANAGEMENT L.P.'s CHRS position was last reported at $0 in 2024-Q1 before the exit.

Question 3

Is BALYASNY ASSET MANAGEMENT L.P. buying or selling CHRS?

Accepted Answer

In 2024-Q1, BALYASNY ASSET MANAGEMENT L.P. exited their CHRS position entirely (-100.0% change in shares).

Question 4

When did BALYASNY ASSET MANAGEMENT L.P. first buy CHRS?

Accepted Answer

Based on available 13F filings, BALYASNY ASSET MANAGEMENT L.P. first reported a position in CHRS in 2018-Q4. They have held the position across 13 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$2.39	0
2023-Q4	Decreased	62,451	-64.4%	$207,962	0.0%	$3.33	0
2023-Q3	New	175,501	-	$656,374	0.0%	$3.74	34
2023-Q2	Exited	0	-100.0%	$0	0.0%	$4.19	0
2023-Q1	Decreased	217,045	-26.6%	$1.5M	0.0%	$6.43	0
2022-Q4	Decreased	295,877	-63.0%	$2.3M	0.0%	$7.92	0
2022-Q3	Decreased	799,950	-25.8%	$7.7M	0.0%	$9.35	0
2022-Q2	New	1.1M	-	$7.8M	0.0%	$7.40	38
2019-Q4	Exited	0	-100.0%	$0	0.0%	$17.54	0
2019-Q3	Decreased	10,564	-95.3%	$214,000	0.0%	$20.48	0
2019-Q2	Decreased	227,199	-35.5%	$5M	0.0%	$22.10	0
2019-Q1	Increased	352,370	+286.8%	$4.8M	0.0%	$13.64	43
2018-Q4	New	91,101	-	$824,000	0.0%	$8.93	34

CHRS13 quarters

CHRS
13 quarters